Brain Stimulation for PTSD
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it excludes those who have had recent medication changes in the past 8 weeks. This might mean you need to be stable on your current medications for at least 8 weeks before joining.
Research suggests that intermittent theta burst stimulation (iTBS), a form of brain stimulation, has shown promise in improving symptoms of PTSD and depression. Studies indicate that iTBS can change brain connectivity patterns, which may help reduce PTSD symptoms.
12345Theta burst stimulation (TBS) has been studied for various psychiatric conditions and is generally considered safe, with most adverse effects being mild. However, there is a theoretical risk of seizures, so it should be used with caution, and more research is needed to fully understand its long-term safety.
12467Continuous theta burst stimulation (cTBS) is a unique treatment for PTSD that uses magnetic pulses to stimulate specific brain areas, offering a novel approach compared to traditional therapies like medication or talk therapy. It is a form of transcranial magnetic stimulation (TMS) that is faster and has shown promise in improving symptoms of depression and PTSD, especially in cases where other treatments have not been effective.
12489Eligibility Criteria
This trial is for right-handed adults aged 18-60 with PTSD, as diagnosed by the DSM-5 criteria. Participants must not have any metal implants in their body.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) and undergo extinction training to reduce arousal symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of startle response and subjective distress